SPECIAL REPORT: 2019 Biopharma Outlook – Facing an Uncertain Future
Xconomy
MARCH 1, 2019
biopharmaceutical industry is dealing with unprecedented threats on several fronts: public backlash against high drug prices, slowing sales, and the possibility of more government regulation. After years of boom times, the U.S. In this Report, you’ll learn: The key indicators that suggest a possible downturn is on the way.
Let's personalize your content